Stay updated on Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a Publications subsection including the Int J Cancer article on TP53 mutation and cetuximab/pembrolizumab. Noted that publications are automatically filled from PubMed.
    Difference
    0.3%
    Check dated 2026-03-13T20:16:40.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.3 appears on the page, replacing v3.4.2; this is a minor update and does not modify study content.
    Difference
    0.1%
    Check dated 2026-03-06T17:50:15.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    - The update changes only the page revision label from v3.4.1 to v3.4.2 and does not affect core study information or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:58:47.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; this is a metadata update with no changes to core content, study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:18:36.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 appears in the page footer. No substantive changes to the study content or layout are detected.
    Difference
    0.1%
    Check dated 2026-01-15T04:31:02.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Added a Locations section listing New York and Ohio as study sites; this consolidates the prior New York Locations and Ohio Locations entries. The page revision was updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed from the footer.
    Difference
    0.3%
    Check dated 2025-12-24T13:47:31.000Z thumbnail image

Stay in the know with updates to Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.